Mark Deneau
No Rating Available
(Learn About Our Rating System)

Mark Deneau, MD, MS, FAAP

Languages spoken: English

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Primary Children's Hospital Outpatient Services at Riverton

3773 West 12600 South
Riverton , UT 84065
801-212-3359
Get Directions

Dr. Mark Deneau is the medical director of the Pediatric Inflammatory Bowel Disease Clinic at Primary Children’s Hospital / Intermountain Healthcare. He leads a multidisciplinary team caring for children and young adults with Crohn’s disease and ulcerative colitis, combining clinical expertise with a deeply personal understanding—Dr. Deneau has lived with IBD himself since his teenage years. That experience shapes his approach to care, allowing him to connect with patients and families on a meaningful level and help them live their best possible lives. When it’s helpful, he’s open about sharing his own journey through medications and surgery.

In addition to his work with IBD, Dr. Deneau treats a wide range of general pediatric gastroenterology conditions, including irritable bowel syndrome (IBS), chronic abdominal pain, and constipation. He takes a thoughtful, conservative approach—avoiding unnecessary procedures or excessive testing whenever possible. He is also part of the liver diseases program and sees patients admitted to the hospital with biliary atresia and liver transplantation.

A dedicated educator, Dr. Deneau teaches and mentors medical students, pediatric residents, and fellows, and has received multiple teaching awards for his excellence in communication. He brings this same clarity and compassion to his clinical work, ensuring patients and families understand their diagnoses, treatments, and medications. He draws on humor to connect with families and ease difficult conversations

His research focuses on liver disease in children with IBD, particularly primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He also leads and participates in hospital-wide quality improvement initiatives aimed at enhancing patient safety and reducing the cost of care for gastrointestinal conditions.

Outside of the hospital, you can find him mountain biking or working on a massive Lego project with his boys.

Specialties

Board Certification

American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Gastroenterology)

Dr. Mark Deneau is the medical director of the Pediatric Inflammatory Bowel Disease Clinic at Primary Children’s Hospital / Intermountain Healthcare. He leads a multidisciplinary team caring for children and young adults with Crohn’s disease and ulcerative colitis, combining clinical expertise with a deeply personal understanding—Dr. Deneau has lived with IBD himself since his teenage years. That experience shapes his approach to care, allowing him to connect with patients and families on a meaningful level and help them live their best possible lives. When it’s helpful, he’s open about sharing his own journey through medications and surgery.

In addition to his work with IBD, Dr. Deneau treats a wide range of general pediatric gastroenterology conditions, including irritable bowel syndrome (IBS), chronic abdominal pain, and constipation. He takes a thoughtful, conservative approach—avoiding unnecessary procedures or excessive testing whenever possible. He is also part of the liver diseases program and sees patients admitted to the hospital with biliary atresia and liver transplantation.

A dedicated educator, Dr. Deneau teaches and mentors medical students, pediatric residents, and fellows, and has received multiple teaching awards for his excellence in communication. He brings this same clarity and compassion to his clinical work, ensuring patients and families understand their diagnoses, treatments, and medications. He draws on humor to connect with families and ease difficult conversations

His research focuses on liver disease in children with IBD, particularly primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He also leads and participates in hospital-wide quality improvement initiatives aimed at enhancing patient safety and reducing the cost of care for gastrointestinal conditions.

Outside of the hospital, you can find him mountain biking or working on a massive Lego project with his boys.

Board Certification and Academic Information

Academic Departments Pediatrics -Professor (Clinical)
Academic Divisions Gastroenterology, Hepatology, & Nutrition
Board Certification
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Gastroenterology)

Education history

Undergraduate Electrical Engineering - Purdue University B.S.
Professional Medical Medicine - Wayne State University M.D.
Residency General Pediatrics - University of Utah Resident
Fellowship Pediatric Gastroenterology, Hepatology and Nutrition - University of Utah Fellow
Graduate Training Clinical Investigation - University of Utah M.S.

Selected Publications

Journal Article

  1. Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Färkkilä M, Petersen B, Rupp C, Hübscher SG, Primary Sclerosing Cholangitis Study Group (2021). Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology, 161, 1764-1775.e5.
  2. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery S (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology (Baltimore, Md.), 58(4), 1392-400.
  3. Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, O'Cathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen M (2017). The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology (Baltimore, Md.), 66(2), 518-527.
  4. Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery S (2021). Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. Hepatology (Baltimore, Md.), 73(3), 1061-1073.
  5. Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammad S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery S (2021). The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology (Baltimore, Md.), 73(3), 1074-1087.
  6. Martinez M, Perito ER, Valentino P, Mack CL, Aumar M, Broderick A, Draijer LG, Fagundes EDT, Furuya KN, Gupta N, Horslen S, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Miloh T, Mogul D, Mohammed S, Ovchinsky N, Rao G, Ricciuto A, Rodrigues Ferreira A, Schwarz KB, Smolka V, Tanaka A, Tessier MEM, Venkat VL, Vitola BE, Woynarowski M, Zerofsky M, Deneau M (2021). Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study. Hepatology (Baltimore, Md.), 74(4), 2047-2057.
  7. Deneau MR, Valentino PL, Mack C, Alqoaer K, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, El-Matary W, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Kim KM, Kolho KL, Koot B, Iorio R, Martinez M, Miloh T, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Woynarowski M, Guthery (2020). Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. Journal of pediatric gastroenterology and nutrition, 70(1), e12-e17.
  8. Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath B (2017). Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. Journal of pediatric gastroenterology and nutrition, 64(4), 639-652.
  9. Laborda TJ, Ricciuto A, Aumar M, Carman N, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Koot BGP, Loomes KM, Lytvyak E, Martinez M, Miloh T, Montano-Loza AJ, Perito ER, Sathya P, Shah U, Shteyer E, Singh R, Taylor A, Valentino PL, Vitola B, Zerofsky M, Zizzo A, Deneau M (2020). Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium. Journal of pediatric gastroenterology and nutrition, 71(4), 459-464.
  10. Deneau M, Book LS, Guthery SL, Jensen M (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. The Journal of pediatrics, 164(4), 714-719.e2.
  11. Chandrakumar A, Loeppky R, Deneau M, El-Matary (2019). Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. The Journal of pediatrics, 215, 144-151.e3.
  12. Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen M (2019). Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. The Journal of pediatrics, 209, 92-96.e1.
  13. Taylor MA, West WB, Guthery SL, Deneau M, Short S (2020). Ketorolac after colectomy for ulcerative colitis in children: An analysis of opioid utilization and postoperative complications. Journal of pediatric surgery, 55(11), 2393-2396.
  14. Jimenez-Rivera C, Ling SC, Ahmed N, Yap J, Aglipay M, Barrowman N, Graitson S, Critch J, Rashid M, Ng VL, Roberts EA, Brill H, Dowhaniuk JK, Bruce G, Bax K, Deneau M, Guttman OR, Schreiber RA, Martin S, Alvarez (2015). Incidence and Characteristics of Autoimmune Hepatitis. Pediatrics, 136(5), 1237-1248.
  15. Lascurain L, Jensen MK, Guthery SL, Holmen J, Deneau (2016). Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis. Inflammatory bowel diseases, 22(1), 146-50.
  16. Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman M (2021). Natural History of¿ Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflammatory bowel diseases, 27(3), 295-302.
  17. Soufi N, Bazerbachi F, Deneau (2018). Post-Transplant Disease Recurrence in Pediatric PSC. Current gastroenterology reports, 20(9), 44.
  18. El-Matary W, Guthery SL, Amir AZ, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Hochberg JT, Horslen S, Kerkar N, Koot BGP, Laborda TJ, Loomes KM, Mack C, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Moroz S, Ovchinsky N, Perito ER, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Soufi N, Valentino PL, Zizzo A, Deneau M (2021). Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis. Clinical gastroenterology and hepatology, 19(5), 1067-1070.e2.
  19. Sandweiss DR, Allen L, Deneau M, Harnsberger J, Pasmann A, Smout R, Mundorff M, Dudley (2018). Implementing a Standardized Constipation-Management Pathway to Reduce Resource Utilization. Academic pediatrics, 18(8), 957-964.
  20. Laborda TJ, Jensen MK, Kavan M, Deneau (2019). Treatment of primary sclerosing cholangitis in children. World journal of hepatology, 11(1), 19-36.
  21. Johnson E, Ermarth A, Deneau (2019). A Novel Care Model for Neonatal Intestinal Failure Patients Is Associated With Cost Savings and Improved Outcomes. Gastroenterology research, 12(2), 93-95.
  22. Mhanni AA, Kozenko M, Hartley JN, Deneau M, El-Matary W, Rockman-Greenberg (2015). Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease. Molecular genetics and metabolism reports, 6, 13-5.
  23. Jaramillo C*, Valentino P, Deneau (2017). Update on Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlap Syndrome in Childhood. Current hepatology reports, 2017(3),
  24. Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis. Hepatology communications, 2(11), 1369-1378.
  25. Deneau M, Mutyala R, Sandweiss D, Harnsberger J, Varier R, Pohl JF, Allen L, Thackeray C, Zobell S, Maloney (2017). Reducing hospital admissions of healthy children with functional constipation: a quality initiative. BMJ open quality, 6(2), e000116.
  26. Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Cal¿¿kan AR, Harputluoglu M, Kabaçam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder A, Parés A, Llovet L, Aky'ld'z M, Arikan C, Manns MP, Taubert R, Weber AL, Schiano TD, Haydel B, Czubkowski P, Socha P, O'dak N, Akamatsu N, Tanaka A, Levy C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M, Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM, Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH, International Autoimmune Hepatitis Group (IAIHG) (2022). Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. Journal of hepatology,
  27. Kastenberg ZJ, Deneau MR, O'Brien EA, Huynh K, Book LS, Srivastava R, Jensen MK, Jaramillo CM, Guthery S (2023). Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study. The Journal of pediatrics, 257, 113339.
  28. Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis D (2023). Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology (Baltimore, Md.), 77(6), E176-E177.
  29. Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis D (2023). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology (Baltimore, Md.), 77(2), 659-702.
  30. Kerur B, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz RM, Karam L, Crowley E, Griffiths AM, Heyman MB, Deneau M, Benkov K, Noe J, Moulton D, Pappa H, Galanko J, Snapper S, Muise AM, Kappelman MD, Benchimol E (2022). Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America. Journal of pediatric gastroenterology and nutrition, 75(1), 64-69.
  31. Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M, Pediatric PSC Consortiu (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Alimentary pharmacology & therapeutics,

Case Report

  1. Jaramillo C, Ermarth AK, Putnam AR, Deneau (2019). Neonatal cholestasis and hepatosplenomegaly caused by congenital dyserythropoietic anemia type 1: A case report. World journal of hepatology, 11(5), 477-482.

Letter

  1. Deneau (2021). REPLY. Hepatology (Baltimore, Md.), 74(3), 1717.
  2. Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian J (2023). Reply: Living donor liver transplantation for people with PSC. Hepatology (Baltimore, Md.), 77(5), E97-E98.

Abstract

  1. Mhanni A, Rockman-Greenberg C, Deneau M, Hartley J (10/1/2014). Mesenteric lymphadenopathy and protein-losing enteropathy in Gaucher disease type 3 despite combined enzyme replacement and substrate reduction therapy [Abstract]. Clin Biochem, 47(15), 139.
  2. *Bazerbachi F, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium [Abstract]. Gastroenterology, 152(5 (supplement 1)), S1062-1064.
  3. *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, *Bazerbacki F, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau M (4/1/2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium [Abstract]. Gastroenterology, 152(5 (Supplement 1)), S1057.
  4. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M. Kyle Jensen, Deneau (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration. Hepatology (Baltimore, Md.), 62(S1), 1038A.
  5. Deneau M, Book L, Guthery SL, Jensen M (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study. Hepatology (Baltimore, Md.), 58(S1),
  6. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen M (2016). Laboratory predictors of longterm prognosis in primary sclerosing cholangitis: data from the pediatric PSC consortium. Hepatology (Baltimore, Md.), 63(1), 350A.
  7. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen M (2016). Ursodeoxycholic acid treatment does not improve liver outcomes in pediatric PSC: a multicenter, international collaboration. Hepatology (Baltimore, Md.), 63(1), 349A.
  8. *Ricciuto A, Kamath B, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen MK, Deneau (2016). Primary sclerosing cholangitis and autoimmune sclerosing cholangitis are associated with similar outcomes: data from the pediatric PSC consortium. Hepatology (Baltimore, Md.), 63(1), 352A.
  9. Deneau M, El-Matary W, Varier R, Auth M, Konidari A, Miloh T, Shteyer E, Ledder O, Abdou R, Vitola B, Homan M, Papadopoulou A, Furuya K, Kim K, Woynarowski M, Gottrand M, Gottrand F, Broderick A, Valentino P, Martinez M, Ricciuto A, Kamath B, Venkat V, Gupta N, Iorio R, Bazerbachi F, El-Youssef M, Kolho K, Amin M, Doan S, Jensen M (2016). The Natural History of Primary Sclerosing Cholangitis in 500 Children: A multicenter, international collaboration. Hepatology (Baltimore, Md.), 63(1), 72A.
  10. Deneau M, *Bazerbachi F, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, *OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2017). Validating the Mayo Model of Primary Sclerosing Cholangitis Outcomes in Children: Data from the Pediatric PSC Consortium. Hepatology (Baltimore, Md.), 66(S1), 649-650A.
  11. Deneau M, *Bazerbachi F, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, *OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Treatment with Ursodeoxycholic Acid: Data from the Pediatric PSC Consortium. Hepatology (Baltimore, Md.), 66(S1), 58A.
  12. Deneau M, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, *Bazerbacki F, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2018). Clinical Outcomes of Oral Vancomycin Therapy in Children in the Pediatric PSC Consortium. Hepatology (Baltimore, Md.), 68(S1),
  13. Deneau M, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, *Bazerbacki F, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2018). Variability in Diagnostic and Therapeutic Practices Between Centers in the Pediatric PSC Consortium. Hepatology (Baltimore, Md.), 68(S1),
  14. *Bazerbachi F, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau (2017). Recurrence of primary sclerosing cholangitis after liver transplantation in children: data from the Pediatric PSC Consortium. Journal of hepatology, 66(Supplement 1), S76.
  15. Sylvia Doan, Wael El-Matary, Raghu Varier, Anastasia Konidari, Marcus Auth, M. Kyle Jensen, Deneau (2015). Predictors of poor outcome in pediatric primary sclerosing cholangitis: a multicenter collaboration. Journal of pediatric gastroenterology and nutrition, 61(S2), 184.
  16. Deneau M, Jensen MK, Holmen J, Williams MS, Bleyl S, Guthery (2012). Pediatric Primary Sclerosing Cholangitis and Inflammatory Bowel Disease in Utah: A Population-Based Study. Journal of pediatric gastroenterology and nutrition, 55(Suppl 1),
  17. Deneau M, Book L, Guthery SL, Jensen M (2013). Sustained immunosuppression-free remission in pediatric autoimmune hepatitis: a population-based study. Journal of pediatric gastroenterology and nutrition, 57(Suppl 1),
  18. Ramakrishna Mutyala, Deneau M, Linda Book, Robin Kim, Ronald Day, M. Kyle Jense (2015). Frequency and Impact of Severe Hepatopulmonary Syndrome on Liver Transplantation in Children. Journal of pediatric gastroenterology and nutrition, 61(S2), S187.
  19. *Lascurain L, Deneau M, Guthery SL, Jensen M (2013). Inflammatory bowel disease activity and distribution in children with and without primary sclerosing cholangitis. Journal of pediatric gastroenterology and nutrition, 57(Suppl 1),
  20. *Lascurain L, Deneau (2015). Inflammatory bowel disease spares the poor but autoimmune hepatitis does not: socioeconomic factors in immune-mediated disease in Utah. Journal of pediatric gastroenterology and nutrition, 61(S2), S174.
  21. Ermarth A, Deneau (2015). Clinical characteristics of very early onset inflammatory bowel disease: a population-based cohort. Journal of pediatric gastroenterology and nutrition, 61(S2), S22.
  22. Mutyala R, Jaramillo C, Ermarth A, Weinheimer C, Jackson WD, Coombs S, Deneau (2016). Early discharge of intestinal failure patients from the NICU: a pilot quality improvement initiative. Journal of pediatric gastroenterology and nutrition, 63(S), S401.
  23. *McClain A, Anderson C, Leukler J, Deneau (2017). Early vs. Late Initiation of Parenteral Nutrition in a Pediatric ICU: A Quality Improvement Initiative. Journal of pediatric gastroenterology and nutrition, 65(S2), S79-S80.
  24. Deneau M, *Mutyala K, Book L, Ermarth A, Guthery S, Harnsberger J, *Jaramillo C, Jackson WD, Jensen MK, Kavan M, *McClain A, OGorman M, Patel R, Pohl JF, Robson J, Sandweiss D, Sutton T, Varier R, Maloney (2017). How We Stopped Admitting Children for Bowel Cleanouts. Journal of pediatric gastroenterology and nutrition, 65(S2), S144-S145.
  25. *Johnson E, Deneau M, Ermarth (2018). A NOVEL CARE MODEL FOR INTESTINAL FAILURE PATIENTS IN THE NICU: EARLIER DISCHARGE, FEWER READMISSIONS, AND MULTIMILLION DOLLAR COST SAVINGS. Journal of pediatric gastroenterology and nutrition, 66(S1),
  26. Deneau M, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, *Bazerbacki F, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2018). MELD and Liver Transplantation in Pediatric Primary Sclerosing Cholangitis, Data From the Pediatric PSC Consortium. Journal of pediatric gastroenterology and nutrition, 66(S1),
  27. *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, *Bazerbacki F, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau (2017). A comparison of primary sclerosing cholangitis with and without associated inflammatory bowel disease: data from the pediatric PSC consortium. 64(Supplement 1), S576.
  28. *Jaramillo C, Guthery S, Deneau (2017). Inflammatory Bowel Disease in Hispanic Children: A Population-Based Study. 65(S2), S39-S40.
  29. Deneau M, Guthery (2017). Cancer is More Common in Children with Inflammatory Bowel Disease Regardless of Immunosuppression Regimen. 65(S2), S232-S233.
  30. Deneau M, *Bazerbachi F, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, *OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2017). Improvement in GGT Predicts Event-Free Survival in Primary Sclerosing Cholangitis Regardless of Ursodeoxycholic Acid Treatment: Data from the Pediatric PSC Consortium. 65(S2), S105-106.
  31. Deneau M, *Bazerbachi F, *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, *OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap (2017). Validating the Mayo Model of Primary Sclerosing Cholangitis Outcomes in Children: Data from the Pediatric PSC Consortium. 65(S2), S162.
  32. *Ricciuto A, Kamath B, *Abdou R, *Amin M, Amir A, Auth M, *Bazerbacki F, Broderick A, *Chan A, *Cotter J, *Doan S, El-Matary W, El-Youssef M, Ferrari F, Furuya K, Gottrand M, Gottrand F, Gupta N, Homan M, Jensen MK, Kim KM, Kolho K, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Sathya P, Shteyer E, Tanaka A, Varier R, Valentino P, Venkat V, Vitola B, Vos M, Vratislav S, Woynarowski M, Yap J, Deneau (2017). Primary Sclerosing Cholangitis with and without Association Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium. 65(S2), S48-S49.

Video/Film/CD/Web/Podcast

  1. Deneau M (2021). The SCOPE Index online.